Results 321 to 330 of about 147,268 (335)
Some of the next articles are maybe not open access.

Can von Willebrand Disease Be Investigated on Combined Hormonal Contraceptives?

Journal of Pediatric and Adolescent Gynecology, 2013
Tania Dumont, Lisa Allen
exaly  

STEC-HUS, atypical HUS and TTP are all diseases of complement activation

Nature Reviews Nephrology, 2012
M. Noris, Federica Mescia, G. Remuzzi
semanticscholar   +1 more source

Therapeutic RNA aptamers in clinical trials.

European Journal of Pharmaceutical Sciences, 2013
P. Sundaram   +3 more
semanticscholar   +1 more source

Variability of von Willebrand factor‐related parameters in endothelial colony forming cells

Journal of Thrombosis and Haemostasis, 2019
A De Jong   +2 more
exaly  

Von Willebrand factor and von Willebrand disease

Von Willebrand disease (vWD) is an autosomally inherited bleeding disorder caused by a deficiency or abnormality of von Willebrand factor (vWF). vWF is a large multimeric glycoprotein that mediates platelet adhesion at the site of vessel injury. Also, it protects factor VIII from proteolytic degradation in the circulation. vWD has a prevalence of about
openaire   +1 more source

Home - About - Disclaimer - Privacy